Primary Objective: To assess sleep satisfaction before and after Zolpidem CR (Ambien CR) administration Secondary Objective: To assess Psychomotor Performance before and after Zolpidem CR (Ambien CR) administration
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Pharmaceutical form: tablet Route of administration: oral Dose regimen: once daily
Investigational Site Number 10
Buenos Aires, Argentina
Investigational Site Number 1
C.a.b.a., Argentina
Investigational Site Number 4
C.a.b.a., Argentina
Investigational Site Number 6
C.a.b.a., Argentina
Sleep satisfaction score (LSEQ = Leeds sleep evaluation questionnaire)
Time frame: at Baseline, at V2 (26 +/- 2 days)
Psychomotor Performance (DSST / Digit Symbol Substitution Test and ESS / Epworth Sleepiness Scale)
Time frame: at Baseline, at V2 (26 +/- 2 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Investigational Site Number 2
Capital Federal, Argentina
Investigational Site Number 3
La Plata, Argentina